Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial

Faster, Cleaner, Better.

Finch Therapeutcs Grp Inc (FNCH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Cash Flow for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2023	12-2022	12-2021	12-2020	12-2017
Cash Flows From Operating Activities
Net Income	-74,754	-114,646	-58,160	-39,341	N/A
Depreciation Amortization	1,520	5,507	2,301	790	N/A
Income taxes - deferred	-3,461	N/A	N/A	N/A	N/A
Accounts receivable	143	350	540	143	N/A
Accounts payable and accrued liabilities	-956	-2,259	2,261	440	N/A
Other Working Capital	-5,420	-1,564	-14,512	4,110	N/A
Other Operating Activity	51,423	37,761	437	2,529	0
Operating Cash Flow	$-31,505	$-74,851	$-67,133	$-31,329	$N/A

Cash Flows From Investing Activities
PPE Investments	1,327	-2,182	-15,921	-2,633	N/A
Investing Cash Flow	$1,327	$-2,182	$-15,921	$-2,633	$N/A

Cash Flows From Financing Activities
Debt Issued	N/A	14,738	N/A	1,808	N/A
Debt Repayment	-15,000	-22	-27	-47	N/A
Common Stock Issued	N/A	289	121,796	59	N/A
Other Financing Activity	-1,155	-132	-2,659	89,655	0
Financing Cash Flow	$-16,155	$14,873	$119,110	$91,475	$N/A

Beginning Cash Position	73,805	135,965	99,909	42,396	N/A
End Cash Position	27,472	73,805	135,965	99,909	N/A
Net Cash Flow	$-46,333	$-62,160	$36,056	$57,513	$N/A

Free Cash Flow
Operating Cash Flow	-31,505	-74,851	-67,133	-31,329	N/A
Capital Expenditure	N/A	-2,182	-15,983	-2,633	N/A
Free Cash Flow	-31,505	-77,033	-83,116	-33,962	0